Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul 29:13:929995.
doi: 10.3389/fimmu.2022.929995. eCollection 2022.

Influence of single-nucleotide polymorphisms in TLR3 (rs3775291) and TLR9 (rs352139) on the risk of CMV infection in kidney transplant recipients

Affiliations

Influence of single-nucleotide polymorphisms in TLR3 (rs3775291) and TLR9 (rs352139) on the risk of CMV infection in kidney transplant recipients

Natalia Redondo et al. Front Immunol. .

Abstract

Risk stratification for cytomegalovirus (CMV) infection after kidney transplantation (KT) remains to be determined. Since endosomal toll-like receptors (TLRs) are involved in viral sensing, we investigated the impact of common single-nucleotide polymorphisms (SNPs) located within TLR3 and TLR9 genes on the occurrence of overall and high-level (≥1,000 IU/ml) CMV infection in a cohort of 197 KT recipients. Homozygous carriers of the minor allele of TLR3 (rs3775291) had higher infection-free survival compared with reference allele carriers (60.0% for TT versus 42.3% for CC/CT genotypes; P-value = 0.050). Decreased infection-free survival was observed with the minor allele of TLR9 (rs352139) (38.2% for TC/CC versus 59.3% for TT genotypes; P-value = 0.004). After multivariable adjustment, the recessive protective effect of the TLR3 (rs3775291) TT genotype was confirmed (adjusted hazard ratio [aHR]: 0.327; 95% CI: 0.167-0.642; P-value = 0.001), as was the dominant risk-conferring effect of TLR9 (rs352139) TC/CC genotypes (aHR: 1.865; 95% CI: 1.170-2.972; P-value = 0.009). Carriers of the TLR9 (rs352139) TC/CC genotypes showed lower CMV-specific interferon-γ-producing CD4+ T-cell counts measured by intracellular cytokine staining compared with the TT genotype (median of 0.2 versus 0.7 cells/μl; P-value = 0.003). In conclusion, TLR3/TLR9 genotyping may inform CMV infection risk after KT.

Keywords: cytomegalovirus; kidney transplantation; single-nucleotide polymorphism (SNP); toll-like receptor 3 (TLR3); toll-like receptor 9 (TLR9).

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Comparison of CMV infection-free survival according to selected genotypes of candidate SNPs: (A) TLR3 (rs3775291) (log-rank P-value = 0.050), (B) TLR9 (rs5743836) (log-rank P-value = 0.063), and (C) TLR9 (rs352139) (log-rank P-value = 0.004). Reference and minor alleles are shown as blue and red curves, respectively. CMV, cytomegalovirus; SNP, single-nucleotide polymorphism.
Figure 2
Figure 2
CMV infection-free survival according to the number of unfavorable genotypes in candidate SNPs (log-rank P-value = 0.002). The unfavorable genotypes were as follows: major C allele of TLR3 (rs3775291) in homozygous or heterozygous state; minor G allele of TLR9 (rs5743836) in homozygous or heterozygous state; and minor C allele of TLR9 (rs352139) in homozygous or heterozygous state. CMV: cytomegalovirus.
Figure 3
Figure 3
Comparison of CMV pp65 and IE-1-specific IFN-γ-producing CD4+ and CD8+ T-cell counts enumerated by intracellular cytokine stating in a subgroup of 31 patients (44 individual monitoring points) between selected genotypes of candidate SNPs: (A) CD4+ and (B) CD8+ T cells according to TLR9 (rs5743836); (C) CD4+ and (D) CD8+ T cells according to TLR9 (rs352139). Horizontal bars and whiskers represent median values and interquartile ranges, respectively. CMV, cytomegalovirus; IFN-γ, interferon-γ.

Similar articles

Cited by

References

    1. Sanclemente G, Moreno A, Navasa M, Lozano F, Cervera C. Genetic variants of innate immune receptors and infections after liver transplantation. World J Gastroenterol (2014) 20(32):11116–30. doi: 10.3748/wjg.v20.i32.11116 - DOI - PMC - PubMed
    1. Meneghini M, Bestard O, Grinyo JM. Immunosuppressive drugs modes of action. Best Pract Res Clin Gastroenterol (2021) 54-55:101757. doi: 10.1016/j.bpg.2021.101757 - DOI - PubMed
    1. Sezgin E, An P, Winkler CA. Host genetics of cytomegalovirus pathogenesis. Front Genet (2019) 10:616. doi: 10.3389/fgene.2019.00616 - DOI - PMC - PubMed
    1. Tyl MD, Betsinger CN, Cristea IM. Virus-host protein interactions as footprints of human cytomegalovirus replication. Curr Opin Virol (2021) 52:135–47. doi: 10.1016/j.coviro.2021.11.016 - DOI - PMC - PubMed
    1. Torre-Cisneros J, Aguado JM, Caston JJ, Almenar L, Alonso A, Cantisan S, et al. . Management of cytomegalovirus infection in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations. Transplant Rev (Orlando) (2016) 30(3):119–43. doi: 10.1016/j.trre.2016.04.001 - DOI - PubMed

MeSH terms